申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US04618610A1
公开(公告)日:1986-10-21
New triazine derivatives represented by the formula: ##STR1## wherein R.sup.1 is hydrogen or halogen; R.sup.2 is a hydroxy, protected hydroxy, amino, cyano, mercapto, lower alkylthio, arylthio, sulfamoyl, lower alkylsulfonylamino, lower alkylureido, arylureido, lower alkyl-thioureido, aryl-thioureido, lower alkenoylamino, lower alkoxycarbonylamino, lower alkoxy(thiocarbonyl)thio, or cyclic or acyclic alkanoylamino in which the cyclic and acyclic alkanoylamino group may have a substituent selected from lower alkoxy, aryl, hydroxyaryl and protected hydroxyaryl; and X is O or S; and pharmaceutically acceptable salt thereof, which are useful in the treatment of hypertension, thrombosis and ulcer in human beings and animals.
新的三嗪衍生物的化学式如下:##STR1## 其中 R.sup.1 为氢或卤素;R.sup.2 为羟基、保护羟基、氨基、氰基、巯基、较低烷基硫基、芳基硫基、磺胺基、较低烷基磺酰胺基、较低烷基脲基、芳基脲基、较低烷基硫脲基、芳基硫脲基、较低烯酰胺基、较低烷氧羰基胺基、较低烷氧(硫代羰基)硫基,或环状或非环状脂肪酰胺基,其中环状和非环状脂肪酰胺基可能具有从较低烷氧基、芳基、羟基芳基和保护羟基芳基中选择的取代基;X 为氧或硫;以及其药学上可接受的盐,可用于治疗人类和动物的高血压、血栓和溃疡。